NCT04686422

Brief Summary

The purpose of this clinical trial is to measure the clinical outcomes of Tetric PowerFill Class I and II restorations cured in 3 seconds with the Bluephase PowerCure curing unit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2017

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 28, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
3.8 years until next milestone

Results Posted

Study results publicly available

May 2, 2025

Completed
Last Updated

October 23, 2025

Status Verified

April 1, 2025

Enrollment Period

3.6 years

First QC Date

December 22, 2020

Results QC Date

April 15, 2025

Last Update Submit

September 26, 2025

Conditions

Outcome Measures

Primary Outcomes (15)

  • FDI 11 - Postoperative Hypersensitivity

    assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable"

    Baseline

  • Pulp Integrity

    Restored teeth are assessed by a cold air stimuli test (air syringe) by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable")

    Baseline

  • Overall Survival Rate

    Restorations were examined by a dentist

    Baseline

  • FDI 11 - Postoperative Hypersensitivity

    assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable"

    6 Month

  • Pulp Integrity

    Restored teeth are assessed by a cold air stimuli test (air syringe) by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable")

    6 Month

  • Overall Survival Rate

    Restorations were examined by a dentist

    6 Month

  • FDI 11 - Postoperative Hypersensitivity

    assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable"

    12 Month

  • Pulp Integrity

    Restored teeth are assessed by a cold air stimuli test (air syringe) by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable")

    12 Month

  • Overall Survival Rate

    Restorations were examined by a dentist

    12 Month

  • FDI 11 - Postoperative Hypersensitivity

    assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable"

    24 Month

  • Pulp Integrity

    Restored teeth are assessed by a cold air stimuli test (air syringe) by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable")

    24 Month

  • Overall Survival Rate

    Restorations were examined by a dentist

    24 Month

  • FDI 11 - Postoperative Hypersensitivity

    assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable"

    36 Month

  • Pulp Integrity

    Restored teeth are assessed by a cold air stimuli test (air syringe) by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable")

    36 Month

  • Overall Survival Rate

    Restorations were examined by a dentist

    36 Month

Secondary Outcomes (5)

  • FDI Criteria (Surface Lustre, Surface Staining, Colour Match, Material Fracture, Occlusal Wear, Tooth Integrity)

    Baseline

  • FDI Criteria (Surface Lustre, Surface Staining, Colour Match, Material Fracture, Occlusal Wear, Tooth Integrity)

    6 Month

  • FDI Criteria (Surface Lustre, Surface Staining, Colour Match, Material Fracture, Occlusal Wear, Tooth Integrity)

    12 Month

  • FDI Criteria (Surface Lustre, Surface Staining, Colour Match, Material Fracture, Occlusal Wear, Tooth Integrity)

    24 Month

  • FDI Criteria (Surface Lustre, Surface Staining, Colour Match, Material Fracture, Occlusal Wear, Tooth Integrity)

    36 Month

Study Arms (1)

Tetric PowerFill Class I and II restorations

EXPERIMENTAL
Device: Tetric PowerFill

Interventions

Tooth (teeth) affected by dental caries or with an existing defective filling will be restored using the PowerCure system.

Tetric PowerFill Class I and II restorations

Eligibility Criteria

Age19 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Each subject must need at least 1 restoration in a vital posterior tooth
  • Must have given written consent to participate in the trial
  • Replacement of defective restorations (i.e. fractured, stained, unaesthetic) with or with-out caries are acceptable
  • Must be available for the required follow-up visits over 3 years
  • Restored teeth must have occlusal contact with opposing teeth or restored teeth
  • Restoration width should be equal to or greater than 1/3 the distance from buccal to lin-gual cusp tips
  • % of the restorations Class II (minimum) and 25% Class I
  • Each Class II will have at least one proximal contact
  • % in molars (minimum) and 25% in premolars
  • All restored teeth must have at least one occlusal contact in habitual closure
  • Must have 20 or more teeth

You may not qualify if:

  • If they have an allergy to ingredients of the materials under investigation (monomers)
  • Have severe medical complications (organ transplants, long term antibiotic or steroid treatment, cancer or are immunocompromised) or disabilities meaning they may not be able to tolerate the time required to complete the restorations or to provide adequate oral hygiene
  • Have xerostomia either by taking medications known to produce xerostomia or those with radiation-induced xerostomia or Sjogren's syndrome - as dry mouth increases tooth and restoration wear as well as the development of caries.
  • Have teeth with advanced or severe periodontitis, rampant caries or poor oral hygiene which may require extraction of the teeth to be restored
  • Present with any systemic or local disorders that contraindicate the dental procedures included in this study
  • Have unstable occlusion
  • Have severe grinding/bruxing or clenching or need TMJ-related therapy
  • Have tooth with exposed pulp during preparation or caries removal
  • Teeth that are non-vital or that exhibit signs of pulpal pathology for restoration
  • Teeth that require cuspal build-ups involving more than one cusp

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UAB School of Dentistry

Birmingham, Alabama, 35294-0007, United States

Location

MeSH Terms

Conditions

Dental Caries

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Results Point of Contact

Title
Team Leader Study Management
Organization
Ivoclar Vivadent AG

Study Officials

  • Nathaniel Lawson, Dr

    UAB School of Dentistry

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2020

First Posted

December 28, 2020

Study Start

December 1, 2017

Primary Completion

June 30, 2021

Study Completion

June 30, 2021

Last Updated

October 23, 2025

Results First Posted

May 2, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations